亞太區股市全面隨美股回落 港股跌幅擴至200點
美股昨晚全面低收續吐0.8%-1.2%,美國10月建築許可環比意外零增長,但新屋動工續升4.9%勝預期,加上藥廠輝瑞指新冠疫苗研發最終試驗結果成功率達95%,支持三大指數早段造好,但紐約市因應疫情嚴峻再度關閉學校,市場擔心疫情惡化重新封城,大市掉頭向,30隻藍籌有27隻下跌,美國批准波音737 MAX客機復飛,刺激該股早段進一步升至223.02美元逾五個月高遇阻倒跌3.2%結束三連漲,可口可樂、安進、Honeywell、聯合健康、前天已急吐9%的Walgreens及雪佛龍依次跌2%-3.2%,拖累道指由早段曾彈147點至29,930,轉為續跌344點或近1.2%收29,438,標普也倒跌近1.2%;但獲納入標指Tesla獲大摩上調目標價,股價續漲10%曾逼近500美元,納指僅反覆續吐0.8%。此外,歐央行行長德拉吉指,不會因為疫苗有好消息而收緊寬鬆政策,較早收市的歐洲主要股市全面反覆升0.3%-0.9%,富時最弱。
道指及標普期貨反覆回穩,但納指期貨反覆續跌0.1%報11,884。亞太區股市早段普遍偏軟。美元兌日圓於亞洲回穩定報103.81,日經繼昨天由逾29年高位回吐逾1%後,今早低見25,532,現造25,618,續吐0.4%。
台灣加權指數扭轉昨天高收續升1.3%屢創紀錄高強勢,今早回吐0.2%報13,747。韓股回落0.2%報2,541。澳洲10月季調後失業率續微升至7%勝預期,澳洲200僅由近9個月高位回落0.1%報6,523。新西蘭股市繼昨天由紀錄高位回吐逾1%結束連日升勢後,今早續吐0.3%報12,569。星股扭三連漲,由逾五個月高位回吐0.5%報2,773。馬股續跌0.9%報1,590。
港股繼昨天反覆續升0.5%曾見26,618逾四個月高後,今早低開83點或0.3%報26,460,在中資金融和科技股及友邦(012399.HK)主導,跌幅擴至211點或0.8%,報26,333。
滬指繼昨天反覆回升0.3%後,今早低開近0.3%報3,339,現造3,335,跌近0.4%;深成繼昨天反覆續吐0.5%後,今早低開近0.2%報13,633,跌幅擴至0.5%報13,585。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.